KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Finished Goods (2016 - 2025)

Sarepta Therapeutics has reported Finished Goods over the past 10 years, most recently at $65.3 million for Q4 2025.

  • For Q4 2025, Finished Goods rose 38.36% year-over-year to $65.3 million; the TTM value through Dec 2025 reached $65.3 million, up 38.36%, while the annual FY2025 figure was $65.3 million, 38.36% up from the prior year.
  • Finished Goods for Q4 2025 was $65.3 million at Sarepta Therapeutics, up from $64.8 million in the prior quarter.
  • Over five years, Finished Goods peaked at $78.0 million in Q3 2024 and troughed at $26.7 million in Q4 2021.
  • A 5-year average of $47.4 million and a median of $47.2 million in 2023 define the central range for Finished Goods.
  • Biggest five-year swings in Finished Goods: surged 713.44% in 2021 and later dropped 23.62% in 2024.
  • Year by year, Finished Goods stood at $26.7 million in 2021, then soared by 42.78% to $38.1 million in 2022, then skyrocketed by 62.02% to $61.8 million in 2023, then dropped by 23.62% to $47.2 million in 2024, then surged by 38.36% to $65.3 million in 2025.
  • Business Quant data shows Finished Goods for SRPT at $65.3 million in Q4 2025, $64.8 million in Q3 2025, and $71.0 million in Q2 2025.